Redeye: Infracom - Acquired Growth Ahead
Redeye retains its positive view of Infracom and raises its Base Case somewhat following its Q2 report. The sales came in broadly in line with our expectations with a continued solid EBIT margin despite being slightly lower than expected. However, our updated 2022E-2023E forecast is mainly due to the recent completion of two acquisitions, which positively affect our valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.